There are five radioisotopes of copper that are suitable for use in nuclear imaging or
targeted radionuclide therapy: copper-67, copper-64, copper-62, copper-61, and copper-60 …

Abstract Copper radioisotopes including copper-60/61/62, and-64 exhibit a wide range of
decay characteristics, making them appropriate choices for diagnostic/therapeutic …

The two longer-lived copper radionuclides, 64Cu and 67Cu, have a long history of
application as biomedical tracers, notably in the use of 64Cu2+ and 67Cu2+ to probe …

Molecular imaging is an important scientific discipline that plays a major role in clinical
medicine and pharmaceutical development. While several imaging modalities including X …

The chemistry, radiochemistry, radiobiology, and radiopharmacology of
radiopharmaceuticals containing copper radionuclides are reviewed. Copper radionuclides …

Copper-64 (T1/2= 12.7 hours; β+: 19%, β−: 38%) has a unique decay profile and can be
used for positron emission tomography imaging and radionuclide therapy. The well …

Copper has five radioisotopes (60Cu, 61Cu, 62Cu, 64Cu, and 67Cu) that can be used in
copper radiopharmaceuticals. These radioisotopes decay by mixed emissions of β+, β-, and …

1.1. BACKGROUND Copper‑64 has several unique attributes that make it a multipurpose
radionuclide with many potential applications. It has a complex decay scheme, with electron …

Summation Copper-64 (T1/2= 12.7 hours; β+, 0.653 MeV [17.8%]; β−, 0.579 MeV [38.4%])
has decay characteristics that allow for positron emission tomography (PET) imaging and …

Many metallic radionuclides are useful in nuclear medicine for imaging by gamma camera
scintigraphy, single photon emission computed tomography (SpeCt) and positron emission …